Menopause in working life
Johanna Kausto, Chief Researcher

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOccupational exposure and asthma
An increasing proportion of the working-age population in Western countries consists of middle-aged or older women. Among EU countries in 2024, the employment rate of women aged 55–64 was 59%. The rate was lowest in Romania, at 43%, and highest in Estonia, at 78% (1). In Finland in 2024, the employment rate for women aged 45–54 was 84%, and 73% for those aged 55–64 (2). In high-income countries, menopause typically begins at an average age of 50–51, with a range of 45–55 years (3, 4). Early menopause occurs between 40–44 years (5). Therefore, a growing number of women in many countries will experience menopause during their professional careers (6).
Menopause affects women’s lives in various ways. Symptoms such as hot flashes, sleep disturbances, mood swings, and fatigue are quite common and may impair work performance, concentration, and the ability to manage tasks (6–10). Additionally, menopause can cause physical symptoms such as joint and muscle pain (11), which may make working more difficult. At the same time, it is important to remember that menopause is not a disease but a natural part of aging (12, 13).
Support for women facing menopause in the workplace
Supporting work ability for those experiencing menopause is an important aspect of gender and age equality in the workplace and overall occupational well-being. Recognizing the need for support has sparked societal discussions, and many countries have developed guidelines for employers and employees on menopause-related practices. These include policies on sick leave reporting, flexible working arrangements, information sharing, training, and workplace modifications. The role of occupational health care is important and tied to the prevailing social and healthcare system, national policies and available resources (14, 15).
The need for research
In Finland, the impact of menopause on work ability has only recently entered public discussion. Recognizing menopause symptoms and providing effective measures to strengthen work ability and work participation has already been mentioned in government policy and current care guidelines (16), but funding for research and concrete measures are still not available. Addressing menopause overlaps with, but is not the same as, the broader issue of improving age management and supporting the careers of employees aged ≥55 (17).
Overall, menopause—as an aspect of women’s health and wellbeing—has received inadequate research attention and funding (18, 19). So far, research evidence on menopausal symptoms and work-related outcomes is mostly correlational and high-quality prospective studies are needed (10). Among the rare prospective cohort studies, one (20) suggested that women with severe menopausal symptoms had a higher risk of employment exit. Another prospective, register-based cohort study reported that an earlier menopausal transition predicted lower work participation and a higher disability pension rate in the following years (21).
The associations between the experiences of menopausal symptoms, the surrounding work context and work-related outcomes are complex, but—so far—the evidence is limited. For example, the experience of menopause and the impact of menopausal symptoms on work ability and work participation may differ by various background factors of the individuals and features of the cultural and social context. Also, menopausal symptoms may modify the relationships between physical and psychosocial work features and work ability and wellbeing (6, 22, 23). At present, there is a lack of adequate evidence to demonstrate the effectiveness of workplace measures for women dealing with menopausal symptoms (15, 24, 25). Qualitative research is important, as experiences of menopause are both individual (although often shared) and influenced by physical, social, and cultural contexts. Menopause can be a sensitive subject (26, 27). In low- and middle-income countries, the topic may be ignored due to negative perceptions, insufficient awareness, and societal stigma (28).
Conclusion
In a rapidly ageing global workforce, menopause in working life is becoming increasingly important and topical. A multidisciplinary approach (26), involving efforts from disciplines such as medicine, public health, economics, psychology, sociology, and gender studies, is needed to comprehensively examine the working life of menopausal women and develop interventions to protect and improve their health, workability, and labor market participation.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Eurostat [cited 15.9.2025]. Available from: https://ec.europa.eu/eurostat
- 2Statistics Finland. Labour Force Survey [cited 15.9.2025]. Available from: https://stat.fi/tilasto/tyti
- 3Davis SR, Pinkerton J, Santoro N, Simoncini T. Menopause-Biology, consequences, supportive care, and therapeutic options. Cell 2023 Sep;186(19):4038–58. 10.1016/j.cell.2023.08.01637678251 · doi ↗ · pubmed ↗
- 4Mishra GD, Chung HF. Menopause, a stage in the life of women. Menopause: A comprehensive approach: second edition 2025. p:3–10. 10.1007/978-3-031-83979-5_1 · doi ↗
- 5Mishra GD, Davies MC, Hillman S, Chung HF, Roy S, Maclaran K et al. Optimising health after early menopause. Lancet 2024 Mar;403(10430):958–68. 10.1016/S 0140-6736(23)02800-338458215 · doi ↗ · pubmed ↗
- 6Safwan N, Saadedine M, Shufelt CL, Kapoor E, Kling JM, Chaudhry R et al. Menopause in the workplace: Challenges, impact, and next steps. Maturitas 2024 Jul;185:107983. 10.1016/j.maturitas.2024.10798338581822 · doi ↗ · pubmed ↗
- 7Hirschberg AL, Polo-Kantola P, Øverlie I, Løkkegaard E, Cockburn E, Rea C et al. Prevalence and impact of vasomotor symptoms associated with menopause among Nordic women: subgroup analysis from an international cross-sectional survey. Acta Obstet Gynecol Scand 2025 Aug;104(8):1575–86. 10.1111/aogs.1513940312875 PMC 12283168 · doi ↗ · pubmed ↗
- 8Nappi RE, Siddiqui E, Todorova L, Rea C, Gemmen E, Schultz NM. Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey. Maturitas 2023 Jan;167:66–74. 10.1016/j.maturitas.2022.09.00636306669 · doi ↗ · pubmed ↗
